USD515202S1 - Tablet - Google Patents

Tablet Download PDF

Info

Publication number
USD515202S1
USD515202S1 US29/209,646 US20964604F USD515202S US D515202 S1 USD515202 S1 US D515202S1 US 20964604 F US20964604 F US 20964604F US D515202 S USD515202 S US D515202S
Authority
US
United States
Prior art keywords
tablet
view
ornamental design
perspective
plan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US29/209,646
Other languages
English (en)
Inventor
Tzyy-Show H. Chen
Craig B. Ikeda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Priority to US29/209,646 priority Critical patent/USD515202S1/en
Priority to CA 109697 priority patent/CA109697S/en
Priority to ECSDI055540 priority patent/ECSDI055540S/es
Priority to AU200510190F priority patent/AU302423S/en
Assigned to MERCK & CO., INC. reassignment MERCK & CO., INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: CHEN, TZYY-SHOW H., IKEDA, CRAIG B.
Publication of USD515202S1 publication Critical patent/USD515202S1/en
Application granted granted Critical
Assigned to MERCK SHARP & DOHME CORP. reassignment MERCK SHARP & DOHME CORP. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: MERCK & CO., INC.
Assigned to SCHERING CORPORATION reassignment SCHERING CORPORATION MERGER (SEE DOCUMENT FOR DETAILS). Assignors: MERCK SHARP & DOHME CORP.
Assigned to MERCK SHARP & DOHME CORP. reassignment MERCK SHARP & DOHME CORP. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: SCHERING CORPORATION
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

US29/209,646 2004-07-19 2004-07-19 Tablet Expired - Lifetime USD515202S1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US29/209,646 USD515202S1 (en) 2004-07-19 2004-07-19 Tablet
CA 109697 CA109697S (en) 2004-07-19 2005-01-10 Pharmaceutical tablet
ECSDI055540 ECSDI055540S (pm) 2004-07-19 2005-01-14
AU200510190F AU302423S (en) 2004-07-19 2005-01-18 Tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29/209,646 USD515202S1 (en) 2004-07-19 2004-07-19 Tablet

Publications (1)

Publication Number Publication Date
USD515202S1 true USD515202S1 (en) 2006-02-14

Family

ID=35768532

Family Applications (1)

Application Number Title Priority Date Filing Date
US29/209,646 Expired - Lifetime USD515202S1 (en) 2004-07-19 2004-07-19 Tablet

Country Status (4)

Country Link
US (1) USD515202S1 (pm)
AU (1) AU302423S (pm)
CA (1) CA109697S (pm)
EC (1) ECSDI055540S (pm)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD553733S1 (en) * 2006-04-07 2007-10-23 Novartis Ag Tablet
USD735315S1 (en) * 2012-06-25 2015-07-28 Celgene Corporation Pharmaceutical tablet
USD744635S1 (en) * 2014-06-26 2015-12-01 Access Business Group International Llc Dietary supplement
USD754841S1 (en) * 2012-02-03 2016-04-26 Johnson & Johnson Consumer Inc. Oral dosage form
USD754840S1 (en) * 2012-02-03 2016-04-26 Johnson & Johnson Consumer Inc. Oral dosage form
USD755949S1 (en) * 2013-07-30 2016-05-10 Reckitt Benckiser Llc Tablet
USD778428S1 (en) * 2012-02-03 2017-02-07 Johnson & Johnson Consumer Inc. Oral dosage form
USD808110S1 (en) * 2015-01-22 2018-01-23 Soremartec S.A Confectionery product
USD813372S1 (en) * 2017-02-22 2018-03-20 Celgene Corporation Pharmaceutical tablet
USD835257S1 (en) * 2017-02-22 2018-12-04 Celgene Corporation Pharmaceutical tablet
USD907760S1 (en) * 2017-01-20 2021-01-12 Société des Produits Nestlé S.A. Orally ingestible tablet
USD1017017S1 (en) * 2021-12-20 2024-03-05 Pfizer Inc. Pill
USD1071139S1 (en) 2023-03-13 2025-04-15 Kenvue Brands Llc Dosage form

Citations (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2687367A (en) 1952-05-05 1954-08-24 Lilly Co Eli Medicinal tablet containing identification fragments
USD258091S (en) 1978-08-31 1981-01-27 Marion Laboratories, Inc. Pharmaceutical tablet
US4693886A (en) 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
US4713248A (en) * 1984-02-10 1987-12-15 A/S Alfred Benzon Diffusion coated multiple-units dosage form
USD301764S (en) 1987-12-21 1989-06-20 Rorer Pharmaceutical Corporation Pharmaceutical tablet
USD302051S (en) 1987-12-21 1989-07-04 Rorer Pharmaceutical Corporation Pharmaceutical tablet
US4851228A (en) 1984-06-20 1989-07-25 Merck & Co., Inc. Multiparticulate controlled porosity osmotic
USD304626S (en) 1987-12-21 1989-11-14 Rorer Pharmaceutical Corporation Pharmaceutical tablet
USD316914S (en) 1989-08-01 1991-05-14 Merrell Dow Pharmaceuticals Inc. Tablet
USD351464S (en) * 1992-09-29 1994-10-11 Merck & Co., Inc. Pharmaceutical product
US5424074A (en) 1989-06-20 1995-06-13 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical composition for potassium supplementation
USD359554S (en) 1994-02-23 1995-06-20 The Procter & Gamble Company Tablet
US5427798A (en) 1992-08-14 1995-06-27 Burroughs Wellcome Co. Controlled sustained release tablets containing bupropion
US5512299A (en) 1992-03-30 1996-04-30 Alza Corporation Method of treating oral inflammatory disease
USD375157S (en) 1992-12-22 1996-10-29 Merck & Co., Inc. Tablet
USD379223S (en) 1995-09-13 1997-05-13 Merck & Co., Inc. Pharmaceutical tablet
USD380825S (en) 1994-10-31 1997-07-08 Merck & Co., Inc. Pharmaceutical tablet
USD383535S (en) * 1996-04-24 1997-09-09 Schering Corporation Tablet
US5770225A (en) 1989-04-28 1998-06-23 Mcneil-Ppc, Inc. Process of preparing a subcoated simulated capsule-like medicament
USD400672S (en) 1996-03-21 1998-11-03 Merck & Co., Inc. Pharmaceutical tablet
USD423141S (en) * 1998-03-20 2000-04-18 Colgate-Palmolive Company Detergent tablet
USD428136S (en) * 1999-04-28 2000-07-11 Hoechst Roussel Vet Bone shaped tablet
USD431076S (en) * 1999-07-07 2000-09-19 Merck & Co., Inc. Tablet
USD434846S (en) 1999-07-07 2000-12-05 Merck & Co., Inc. Tablet
USD459798S1 (en) * 2001-03-26 2002-07-02 Aventis Pharma S.A. Pill tablet

Patent Citations (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2687367A (en) 1952-05-05 1954-08-24 Lilly Co Eli Medicinal tablet containing identification fragments
USD258091S (en) 1978-08-31 1981-01-27 Marion Laboratories, Inc. Pharmaceutical tablet
US4713248A (en) * 1984-02-10 1987-12-15 A/S Alfred Benzon Diffusion coated multiple-units dosage form
US4851228A (en) 1984-06-20 1989-07-25 Merck & Co., Inc. Multiparticulate controlled porosity osmotic
US4693886A (en) 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
USD301764S (en) 1987-12-21 1989-06-20 Rorer Pharmaceutical Corporation Pharmaceutical tablet
USD302051S (en) 1987-12-21 1989-07-04 Rorer Pharmaceutical Corporation Pharmaceutical tablet
USD304626S (en) 1987-12-21 1989-11-14 Rorer Pharmaceutical Corporation Pharmaceutical tablet
US5770225A (en) 1989-04-28 1998-06-23 Mcneil-Ppc, Inc. Process of preparing a subcoated simulated capsule-like medicament
US5424074A (en) 1989-06-20 1995-06-13 Otsuka Pharmaceutical Co., Ltd. Pharmaceutical composition for potassium supplementation
USD316914S (en) 1989-08-01 1991-05-14 Merrell Dow Pharmaceuticals Inc. Tablet
US5512299A (en) 1992-03-30 1996-04-30 Alza Corporation Method of treating oral inflammatory disease
US5427798A (en) 1992-08-14 1995-06-27 Burroughs Wellcome Co. Controlled sustained release tablets containing bupropion
USD351464S (en) * 1992-09-29 1994-10-11 Merck & Co., Inc. Pharmaceutical product
USD375157S (en) 1992-12-22 1996-10-29 Merck & Co., Inc. Tablet
USD359554S (en) 1994-02-23 1995-06-20 The Procter & Gamble Company Tablet
USD380825S (en) 1994-10-31 1997-07-08 Merck & Co., Inc. Pharmaceutical tablet
USD379223S (en) 1995-09-13 1997-05-13 Merck & Co., Inc. Pharmaceutical tablet
USD400672S (en) 1996-03-21 1998-11-03 Merck & Co., Inc. Pharmaceutical tablet
USD383535S (en) * 1996-04-24 1997-09-09 Schering Corporation Tablet
USD423141S (en) * 1998-03-20 2000-04-18 Colgate-Palmolive Company Detergent tablet
USD428136S (en) * 1999-04-28 2000-07-11 Hoechst Roussel Vet Bone shaped tablet
USD431076S (en) * 1999-07-07 2000-09-19 Merck & Co., Inc. Tablet
USD434846S (en) 1999-07-07 2000-12-05 Merck & Co., Inc. Tablet
USD459798S1 (en) * 2001-03-26 2002-07-02 Aventis Pharma S.A. Pill tablet

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USD553733S1 (en) * 2006-04-07 2007-10-23 Novartis Ag Tablet
USD778428S1 (en) * 2012-02-03 2017-02-07 Johnson & Johnson Consumer Inc. Oral dosage form
USD754841S1 (en) * 2012-02-03 2016-04-26 Johnson & Johnson Consumer Inc. Oral dosage form
USD754840S1 (en) * 2012-02-03 2016-04-26 Johnson & Johnson Consumer Inc. Oral dosage form
USD735315S1 (en) * 2012-06-25 2015-07-28 Celgene Corporation Pharmaceutical tablet
USD755949S1 (en) * 2013-07-30 2016-05-10 Reckitt Benckiser Llc Tablet
USD744635S1 (en) * 2014-06-26 2015-12-01 Access Business Group International Llc Dietary supplement
USD808110S1 (en) * 2015-01-22 2018-01-23 Soremartec S.A Confectionery product
USD907760S1 (en) * 2017-01-20 2021-01-12 Société des Produits Nestlé S.A. Orally ingestible tablet
USD813372S1 (en) * 2017-02-22 2018-03-20 Celgene Corporation Pharmaceutical tablet
USD835257S1 (en) * 2017-02-22 2018-12-04 Celgene Corporation Pharmaceutical tablet
USD858741S1 (en) * 2017-02-22 2019-09-03 Celgene Corporation Pharmaceutical tablet
USD835258S1 (en) 2017-02-22 2018-12-04 Celgene Corporation Pharmaceutical tablet
USD1017017S1 (en) * 2021-12-20 2024-03-05 Pfizer Inc. Pill
USD1071139S1 (en) 2023-03-13 2025-04-15 Kenvue Brands Llc Dosage form

Also Published As

Publication number Publication date
ECSDI055540S (pm) 2005-04-18
CA109697S (en) 2006-05-17
AU302423S (en) 2005-07-18

Similar Documents

Publication Publication Date Title
USD522876S1 (en) Bottle
USD520897S1 (en) Double shank ring
USD520185S1 (en) Capsule
USD525063S1 (en) Dispenser
USRE43072E1 (en) Spotlight
USD502121S1 (en) Ring
USD532577S1 (en) Winch
USD508083S1 (en) Pen
USD505330S1 (en) Bottle
USD527643S1 (en) Bottle
USD548098S1 (en) Bottle
USD519997S1 (en) Tablet
USD535697S1 (en) Pen
USD525621S1 (en) Tablet
USD516435S1 (en) Bottle
USD581312S1 (en) Jewelry setting
USD532521S1 (en) Pacifier
USD502875S1 (en) Bottle
USD525465S1 (en) Dispenser
USD526609S1 (en) Wheel
USD536275S1 (en) Ring
USD512741S1 (en) Pen
USD519491S1 (en) Loudspeaker
USD519901S1 (en) Wheel
USD513766S1 (en) Pen